Skip to main content
UniHealth

Doctor search

Daniel A Brinton, MD

Ophthalmology · Oakland

NPI 1114919495

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
18
4 carriers
Offices
3
Since medical school
39 years
University of California, San Francisco School of Medicine, 1987

Offices

3 locations · East Bay Retina Consultants A Medical Group Inc · 6 clinicians in this group

Looking this up.

Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · San Ramon Regional Medical Center. That is not proof they admit you there this week.

Plans that list them

18 plans · 4 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brinton’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

18 of 18 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
  • San Ramon Regional Medical CenterSan Ramon, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 3 of 5 · 65% would definitely recommend it
    Overall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp

Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Alta Bates Summit Medical Center - Alta Bates Camp
Clostridium Difficile (C.Diff)Infections0.298BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.18 (0.16 to 2.2) · 730 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.87 (0.51 to 1.23)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths188.12 (132.31 to 243.94) · 50 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths6.8 · 50 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.8 · 41 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.4 · 189 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.6 · 184 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 103 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 1,585 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.4) · 3,929 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.31 (0.11 to 0.51) · 3,954 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.15 (0.95 to 5.36) · 754 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.62 (0 to 3.33) · 325 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.99 (0.39 to 3.59) · 717 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.85 (2.27 to 19.44) · 326 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.79 (1.08 to 8.49) · 302 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.68 (0.19 to 3.18) · 184 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.17 (0 to 0.88) · 3,240 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.4 · 161 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.207No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.48No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.785No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.4 · 243 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-58.2 · 194 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-12.3 · 177 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 209 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.4 (3.8 to 7.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.2 (9.4 to 15.5) · 215 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits4.8 · 150 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.2 · 81 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.4 (10 to 18.1) · 315 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.2) · 137 casesNo differentJan 2024 – Dec 2024

What patients said (449 patients answered, 15% of those asked)

Patient survey stars by topic at Alta Bates Summit Medical Center - Alta Bates Camp
Cleanliness2
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information2
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Alta Bates Summit Medical Center - Alta Bates Camp
Room was "always" clean62%
Nurses "always" communicated well72%
Doctors "always" communicated well75%
Staff "always" explained53%
Yes, staff "did" give patients this information82%
Yes, staff "did" give patients information about help after discharge82%
Doctors "always" explained things so they could understand68%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)58%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand67%
Nurses "always" listened carefully66%
Nurses "always" treated them with courtesy and respect81%
"Always" quiet at night49%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects38%
Yes, staff "did" give patients information about possible symptoms83%
See every measure and the patient survey for San Ramon Regional Medical Center

Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at San Ramon Regional Medical Center
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.94 (0 to 1.97) · 507 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.83 (0.44 to 1.22)No differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths8.1 · 36 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.8 · 87 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.2 · 195 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.7 · 284 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.5 · 63 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.2 · 1,118 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.4) · 2,515 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.29 (0.08 to 0.49) · 2,618 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.62 (1.26 to 5.98) · 588 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0 to 3.14) · 282 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.34 (0.72 to 3.97) · 598 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.12 (0.84 to 15.4) · 258 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.08 (0.25 to 7.91) · 225 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.02 (0.52 to 3.52) · 241 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.32 (0 to 1.29) · 2,110 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.8 · 73 casesNoneApr 2023 – Mar 2025
Clostridium Difficile (C.Diff)Infections0.553No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.104No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.9 · 84 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.2 · 186 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits39.6 · 79 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-10.3 · 227 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-5.2 · 305 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.6 · 314 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.9 · 84 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.7 · 37 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (9.4 to 17.3) · 86 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.8 to 1.5) · 256 casesNo differentJan 2024 – Dec 2024

What patients said (642 patients answered, 25% of those asked)

Patient survey stars by topic at San Ramon Regional Medical Center
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at San Ramon Regional Medical Center
Room was "always" clean70%
Nurses "always" communicated well75%
Doctors "always" communicated well75%
Staff "always" explained56%
Yes, staff "did" give patients this information84%
Yes, staff "did" give patients information about help after discharge83%
Doctors "always" explained things so they could understand69%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect80%
Patients who gave a rating of "9" or "10" (high)65%
Staff "always" explained new medications70%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect83%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital65%
Staff "always" explained possible side effects41%
Yes, staff "did" give patients information about possible symptoms85%

Original Medicare doctor bills

$1,157,184

Medicare paid this office $1,157,184 for 1,141 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, aflibercept, 1 mg59$523,726None
Injection of drug into eye266$156,300$113
Imaging of retina985$93,265$37
Established patient problem focused exam of visual system790$90,526$79
Compounded drug, not otherwise classified204$81,936None
See all 17 services
Every Original Medicare service billed
Injection, aflibercept, 1 mg59$523,726None
Injection of drug into eye266$156,300$113
Imaging of retina985$93,265$37
Established patient problem focused exam of visual system790$90,526$79
Compounded drug, not otherwise classified204$81,936None
Injection, faricimab-svoa, 0.1 mg12$75,915None
Established patient complete exam of visual system171$22,139$115
Exam of retinal blood vessels using a special camera after injection of a dye82$14,773$172
Removal of membrane of retina13$14,094$1,084
New patient visit (30+ min)135$12,528$93
Extended exam of the back part of the eye with retinal drawing345$8,269$21
New patient visit (45+ min)53$7,403$140
Photocoagulation treatment to prevent detachment of retina15$3,866$242
Short return visit (20+ min)15$1,079$72
2d ultrasound scan of eye tissue and structures15$1,025$47
Exam of visual field with extended testing13$848$61
Photography of the retina18$636$35

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Injection of drug into eye1,7781,5221,5521,5341,3291,382
Photocoagulation treatment to prevent detachment of retina––1215–16
Removal of membrane of retina12––17–13
Destruction of leaking blood vessels of retina using laser––17–––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

1,141 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 19% · Women 55% · Also on Medicaid 14% · Health risk score 1.30. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 71% · Diabetes 32% · Chronic kidney disease 27% · Coronary heart disease 22% · Atrial fibrillation 17% · Cancer 15% · Depression 15% · Heart failure 13% · COPD 9% · Stroke 7% · Dementia 4%.

The office billed $3,755,642, Medicare allowed $1,501,140 and paid $1,157,184; for 10,829 services of 47 kinds; $608,369 of it was for drugs given in the office and $548,816 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20241,14110,829761.30$3,755,642$1,157,184
20239618,124771.28$3,370,027$1,033,164
20221,1568,484771.31$3,951,564$1,223,981
20211,0518,472761.32$3,943,134$1,216,907
20201,0637,636761.41$3,534,161$1,008,473
20191,0838,389761.45$3,624,486$1,012,549
20181,1408,120761.39$2,968,345$1,011,576
20171,0197,818761.35$2,860,726$933,696
20169727,407771.42$2,440,016$797,068
20151,0408,351771.35$2,854,127$790,171
20141,0247,699761.13$2,319,007$635,727
20131,0777,192761.22$2,120,348$584,543

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 13 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg59$516,900None
Injection of drug into eye249$149,902$113
Compounded drug, not otherwise classified193$81,621None
Imaging of retina825$80,819$37
Established patient problem focused exam of visual system624$69,484$79
Established patient complete exam of visual system147$17,286$108
Exam of retinal blood vessels using a special camera after injection of a dye62$9,056$146
New patient visit (30+ min)77$7,344$95
Extended exam of the back part of the eye with retinal drawing281$6,514$21
New patient visit (45+ min)29$4,586$158
Short return visit (20+ min)44$2,563$58
Exam of visual field with extended testing13$756$58
2d ultrasound scan of eye tissue and structures12$671$48

2022: 18 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg74$631,847None
Injection of drug into eye317$171,825$112
Compounded drug, not otherwise classified241$94,841None
Imaging of retina979$93,858$37
Established patient problem focused exam of visual system447$47,763$85
Short return visit (20+ min)407$30,034$66
Removal of membrane of retina16$18,293$1,076
New patient visit (30+ min)161$15,010$93
Established patient complete exam of visual system105$14,554$123
New patient visit (45+ min)70$9,150$131
Exam of retinal blood vessels using a special camera after injection of a dye64$9,086$130
Extended exam of the back part of the eye with retinal drawing304$7,432$21
Return visit (30+ min)62$6,840$101
Photocoagulation treatment to prevent detachment of retina13$3,532$235
Exam of visual field with extended testing17$1,008$56
Photography of the retina29$973$32
2d ultrasound scan of eye tissue and structures13$663$44
Extended exam of the back part of the eye with optic nerve drawing12$179$14

2021: 15 services

Original Medicare services billed in 2021
Injection, aflibercept, 1 mg62$617,828None
Injection of drug into eye274$176,477$114
Compounded drug, not otherwise classified214$97,793None
Imaging of retina881$92,083$38
Short return visit (20+ min)649$69,691$76
Return visit (30+ min)179$24,460$113
New patient visit (45+ min)92$13,138$143
New patient visit (30+ min)134$12,649$94
Exam of retinal blood vessels using a special camera after injection of a dye74$9,339$120
Extended exam of the back part of the eye with retinal drawing280$6,417$21
Photocoagulation treatment to prevent detachment of retina11$6,219$518
Destruction of leaking blood vessels of retina using laser12$5,310$312
Photography of the retina74$2,608$33
2d ultrasound scan of eye tissue and structures21$1,609$49
Injection, triamcinolone acetonide, not otherwise specified, 10 mg11$99None

2020: 14 services

Original Medicare services billed in 2020
Injection, aflibercept, 1 mg58$505,133None
Injection of drug into eye311$150,046$99
Compounded drug, not otherwise classified259$96,340None
Imaging of retina871$82,688$37
Established patient problem focused exam of visual system660$64,602$75
Established patient complete exam of visual system129$15,367$110
New patient visit (30+ min)98$9,136$93
New patient visit (45+ min)59$8,543$145
Extended exam of the back part of the eye with retinal drawing265$6,309$21
Exam of retinal blood vessels using a special camera after injection of a dye48$5,148$107
Injection, bevacizumab, 10 mg33$3,060None
Photography of the retina62$2,560$41
Return visit (30+ min)14$805$58
Extended exam of the back part of the eye with optic nerve drawing40$566$13

2019: 18 services

Original Medicare services billed in 2019
Injection, aflibercept, 1 mg52$468,813None
Injection of drug into eye312$164,843$93
Imaging of retina842$86,615$37
Injection, bevacizumab, 10 mg264$81,198None
Established patient problem focused exam of visual system498$53,642$77
Established patient complete exam of visual system124$15,724$114
Short return visit (20+ min)244$15,455$59
Compounded drug, not otherwise classified124$13,634None
Removal of membrane of retina12$13,203$1,100
New patient visit (30+ min)100$9,403$94
Examination of eye by ophthalmoscope with retinal drawing248$9,150$23
New patient visit (45+ min)60$8,302$138
Exam of retinal blood vessels using a special camera after injection of a dye86$8,003$91
Photography of the retina111$5,010$44
1d and 2d ultrasound scan of eye tissue and structures15$1,658$111
Short return visit17$659$39
Examination of eye by ophthalmoscope with retinal drawing12$321$21
Injection, triamcinolone acetonide, not otherwise specified, 10 mg15$136None

2018: 18 services

Original Medicare services billed in 2018
Injection, aflibercept, 1 mg52$484,481None
Injection of drug into eye290$151,061$92
Imaging of retina903$88,354$38
Injection, bevacizumab, 10 mg258$79,171None
Established patient problem focused exam of visual system365$34,161$73
Short return visit (20+ min)480$33,903$62
Removal of membrane of retina13$13,959$1,074
New patient visit (30+ min)148$12,859$87
New patient visit (45+ min)89$12,634$142
Established patient complete exam of visual system104$11,600$101
Photocoagulation treatment to prevent detachment of retina20$11,056$503
Examination of eye by ophthalmoscope with retinal drawing243$7,136$21
Exam of retinal blood vessels using a special camera after injection of a dye68$6,116$85
Photography of the retina90$4,749$50
Return visit (30+ min)34$3,419$101
Short return visit18$671$37
Examination of eye by ophthalmoscope with retinal drawing17$396$21
Injection, triamcinolone acetonide, not otherwise specified, 10 mg13$102None

2017: 18 services

Original Medicare services billed in 2017
Injection, aflibercept, 1 mg46$435,532None
Injection of drug into eye282$147,241$87
Injection, bevacizumab, 10 mg247$79,178None
Imaging of retina799$77,728$35
Established patient problem focused exam of visual system313$30,173$76
Removal of membrane of retina26$27,395$1,015
Short return visit (20+ min)406$25,313$54
Photocoagulation treatment to prevent detachment of retina24$12,719$471
Established patient complete exam of visual system88$10,807$110
New patient visit (45+ min)80$10,323$129
New patient visit (30+ min)117$10,079$86
Return visit (30+ min)76$6,183$78
Examination of eye by ophthalmoscope with retinal drawing199$6,069$20
Photography of the retina93$5,775$61
Destruction of leaking blood vessels of retina using laser11$5,456$303
Exam of retinal blood vessels using a special camera after injection of a dye71$5,143$71
2d ultrasound scan of eye tissue and structures13$1,700$85
Examination of eye by ophthalmoscope with retinal drawing16$456$22

2016: 15 services

Original Medicare services billed in 2016
Injection, aflibercept, 1 mg40$348,870None
Injection of drug into eye289$144,981$85
Injection, bevacizumab, 10 mg264$80,448None
Imaging of retina759$75,885$38
Short return visit (20+ min)598$47,590$56
Return visit (30+ min)118$11,461$83
Exam of retinal blood vessels using a special camera after injection of a dye59$10,084$96
Removal of membrane of retina11$10,021$911
New patient visit (45+ min)72$9,397$131
New patient visit (30+ min)88$7,518$85
Photocoagulation treatment to prevent detachment of retina11$7,081$472
Photography of the retina79$5,236$65
Examination of eye by ophthalmoscope with retinal drawing183$4,934$18
Established patient problem focused exam of visual system27$1,954$67
2d ultrasound scan of eye tissue and structures15$1,431$80

2015: 19 services

Original Medicare services billed in 2015
Injection, aflibercept, 1 mg28$244,351None
Injection of drug into eye302$168,785$87
Injection, bevacizumab, 10 mg286$93,617None
Imaging of retina785$74,273$38
Short return visit (20+ min)645$52,297$57
Exam of retinal blood vessels using a special camera after injection of a dye93$17,486$96
Removal of membrane of retina16$16,424$1,027
Return visit (30+ min)150$14,058$87
Destruction of leaking blood vessels of retina using laser11$14,040$878
New patient visit (45+ min)83$11,305$136
New patient visit (30+ min)126$10,732$85
Photocoagulation treatment to prevent detachment of retina16$7,625$477
Photography of the retina110$7,392$66
Examination of eye by ophthalmoscope with retinal drawing211$6,664$20
Destruction of growth of retina using a laser11$4,957$451
Established patient problem focused exam of visual system29$2,044$66
2d ultrasound scan of eye tissue and structures15$1,574$83
Established patient complete exam of visual system12$1,126$94
Examination of eye by ophthalmoscope with retinal drawing14$398$22

2014: 17 services

Original Medicare services billed in 2014
Injection of drug into eye275$154,385$89
Injection, aflibercept, 1 mg18$118,381None
Injection, bevacizumab, 10 mg263$83,750None
Imaging of retina709$70,508$39
Short return visit (20+ min)664$58,852$57
Exam of retinal blood vessels using a special camera after injection of a dye93$17,468$96
Removal of membrane of retina11$13,261$1,206
New patient visit (30+ min)145$12,212$84
Return visit (30+ min)122$11,756$86
New patient visit (45+ min)82$10,866$133
Destruction of growth of retina using a laser13$7,655$478
Photography of the retina107$7,266$66
Examination of eye by ophthalmoscope with retinal drawing214$6,863$20
Photocoagulation treatment to prevent detachment of retina12$6,689$478
Established patient problem focused exam of visual system39$2,898$64
2d ultrasound scan of eye tissue and structures24$2,315$83
Examination of eye by ophthalmoscope with retinal drawing22$754$24

2013: 18 services

Original Medicare services billed in 2013
Injection of drug into eye272$136,733$88
Injection, bevacizumab, 10 mg260$75,230None
Imaging of retina646$61,285$39
Short return visit (20+ min)639$55,494$56
Injection, aflibercept, 1 mg14$54,641None
Exam of retinal blood vessels using a special camera after injection of a dye124$24,675$100
Removal of membrane of retina19$22,745$1,197
Return visit (30+ min)140$13,312$86
New patient visit (45+ min)98$13,236$135
New patient visit (30+ min)131$11,663$89
Photocoagulation treatment to prevent detachment of retina22$11,104$483
Photography of the retina137$9,446$67
Examination of eye by ophthalmoscope with retinal drawing218$6,736$20
Established patient problem focused exam of visual system77$5,811$69
2d ultrasound scan of eye tissue and structures27$3,260$84
New patient complete exam of visual system14$1,693$121
Examination of eye by ophthalmoscope with retinal drawing30$1,010$25
Exam of visual field with extended testing12$587$49

Medicaid work

$62,366 in 2024

Medicaid paid $62,366 for 1,114 billed services this clinician did in 2024, up to 55 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Intravitreal injection of a pharmacologic agent (separate procedure)251$31,930
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina451$9,649
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient225$8,045
Injection, bevacizumab, 10 mg64$6,194
New patient visit (30+ min)61$5,548
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral62$1,000
Medicaid work by year
20241,114655$62,366
2023975552$48,382
20221,070849$46,785
20211,252551$51,825
2020941554$33,256
20191,376654$74,827
20181,226549$52,400
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Intravitreal injection of a pharmacologic agent (separate procedure)290$30,691
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina449$8,047
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient171$5,303
Injection, bevacizumab, 10 mg52$4,271
Compounded drug, not otherwise classified13$70

2022

Largest Medicaid services in 2022
Intravitreal injection of a pharmacologic agent (separate procedure)296$26,713
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina471$8,480
Short return visit (20+ min)102$4,253
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient65$2,498
New patient visit (30+ min)30$2,379
Ophthalmoscopy, extended; with retinal drawing and scleral depression of peripheral retinal disease (eg, for retinal tear, retinal detachment, retinal tumor) with interpretation and report, unilateral or bilateral67$1,108
Injection, bevacizumab, 10 mg12$1,019
Compounded drug, not otherwise classified27$336

2021

Largest Medicaid services in 2021
Intravitreal injection of a pharmacologic agent (separate procedure)369$31,672
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina521$7,842
Short return visit (20+ min)198$7,216
Injection, bevacizumab, 10 mg42$4,005
Compounded drug, not otherwise classified122$1,090

2020

Largest Medicaid services in 2020
Intravitreal injection of a pharmacologic agent (separate procedure)313$20,029
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina426$5,167
Injection, bevacizumab, 10 mg49$4,213
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient123$3,786
Compounded drug, not otherwise classified30$61

2019

Largest Medicaid services in 2019
Intravitreal injection of a pharmacologic agent (separate procedure)420$44,465
Injection, bevacizumab, 10 mg335$15,852
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina476$7,511
New patient visit (30+ min)45$3,518
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient75$2,302
Short return visit (20+ min)25$1,180

2018

Largest Medicaid services in 2018
Intravitreal injection of a pharmacologic agent (separate procedure)384$25,490
Injection, bevacizumab, 10 mg306$15,361
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina481$9,057
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient43$1,617
New patient visit (30+ min)12$875

Drugs they prescribed that Part D paid

$11,246

Pharmacies billed $11,246 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

174 generic and 97 brand-name prescriptions · $11,246 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Prednisolone Acetate73$4,330$59
Ketorolac Tromethamine72$1,882$26
Timolol Maleate30$307$10
Latanoprost20$278$14
Neomycin-Polymyxin-Dexameth17$120$7
See all 6 drugs
Every Part D drug this clinician prescribed
Prednisolone Acetate73$4,330$59
Ketorolac Tromethamine72$1,882$26
Timolol Maleate30$307$10
Latanoprost20$278$14
Neomycin-Polymyxin-Dexameth17$120$7
Brimonidine11$116$11

Year by year

Part D prescribing by year
202427187None36%$11,246
202325284None35%$16,055
2022261990% (0)44%$23,776
202130387None42%$20,208
202030380None47%$22,732
201933898None45%$22,935
201830293NoneNone$16,957
201738290None40%$20,870
2016497108None48%$34,255
2015504118NoneNone$39,689
20145781342% (11)60%$47,616
20133981194% (14)57%$25,796

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 5 drugs

Part D drugs prescribed in 2023
Prednisolone Acetate48$3,249$68
Ketorolac Tromethamine45$1,499$33
Timolol Maleate35$880$25
Latanoprost31$330$11
Brimonidine15$303$20

2022: 4 drugs

Part D drugs prescribed in 2022
Prednisolone Acetate72$5,129$71
Ketorolac Tromethamine38$1,746$46
Latanoprost34$833$24
Timolol Maleate28$567$20

2021: 7 drugs

Part D drugs prescribed in 2021
Prednisolone Acetate59$2,988$51
Ketorolac Tromethamine40$1,835$46
Latanoprost49$824$17
Timolol Maleate44$769$17
Olopatadine11$413$38
Diclofenac13$275$21
Brimonidine14$228$16

2020: 6 drugs

Part D drugs prescribed in 2020
Prednisolone Acetate70$3,994$57
Alphagan P16$2,852$178
Olopatadine31$1,601$52
Ketorolac Tromethamine29$901$31
Latanoprost43$644$15
Timolol Maleate38$437$11

2019: 6 drugs

Part D drugs prescribed in 2019
Prednisolone Acetate83$4,191$50
Olopatadine35$3,826$109
Timolol Maleate41$1,018$25
Ketorolac Tromethamine35$724$21
Latanoprost39$550$14
Dorzolamide-Timolol16$457$29

2018: 6 drugs

Part D drugs prescribed in 2018
Prednisolone Acetate55$2,491$45
Combigan11$1,856$169
Latanoprost44$1,018$23
Ketorolac Tromethamine43$938$22
Dorzolamide-Timolol16$546$34
Timolol Maleate44$504$11

2017: 9 drugs

Part D drugs prescribed in 2017
Prednisolone Acetate73$3,570$49
Nevanac12$2,822$235
Combigan17$2,609$153
Ketorolac Tromethamine65$1,047$16
Latanoprost37$879$24
Dorzolamide20$603$30
Timolol Maleate51$578$11
Dorzolamide-Timolol19$348$18
Carteolol11$156$14

2016: 12 drugs

Part D drugs prescribed in 2016
Nevanac33$7,385$224
Prednisolone Acetate112$4,911$44
Pataday20$3,509$175
Combigan16$2,494$156
Bromfenac12$1,933$161
Ketorolac Tromethamine57$912$16
Timolol Maleate58$802$14
Dorzolamide19$668$35
Latanoprost48$600$13
Dorzolamide-Timolol20$391$20
Ofloxacin11$170$15
Brimonidine11$161$15

2015: 13 drugs

Part D drugs prescribed in 2015
Nevanac51$11,042$217
Prednisolone Acetate94$5,390$57
Pataday26$4,028$155
Bromfenac18$3,275$182
Travatan Z16$2,309$144
Combigan13$1,616$124
Ketorolac Tromethamine44$790$18
Timolol Maleate64$703$11
Latanoprost49$665$14
Dorzolamide21$597$28
Dorzolamide-Timolol15$519$35
Brimonidine16$516$32
Ofloxacin12$225$19

2014: 15 drugs

Part D drugs prescribed in 2014
Nevanac68$11,810$174
Prednisolone Acetate140$7,635$55
Bromfenac31$4,234$137
Acetazolamide17$3,645$214
Travatan Z20$3,084$154
Pataday15$2,043$136
Combigan13$1,388$107
Ketorolac Tromethamine54$1,383$26
Brimonidine18$1,187$66
Pilocarpine12$891$74
Dorzolamide14$436$31
Timolol Maleate41$364$9
Dorzolamide-Timolol12$322$27
Latanoprost24$293$12
Ofloxacin26$240$9

2013: 10 drugs

Part D drugs prescribed in 2013
Nevanac36$5,528$154
Acetazolamide11$3,186$290
Prednisolone Acetate97$2,346$24
Lumigan11$1,738$158
Brimonidine17$1,692$100
Ketorolac Tromethamine37$1,153$31
Latanoprost23$631$27
Dorzolamide12$402$34
Ofloxacin30$266$9
Timolol Maleate22$234$11

Money from drug and device companies

$27 in 2025

Industry payments by year
202511None$27
202422None$46
202322None$49
201911None$123

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AmgenTepezza$27
1 payment
  • Meals for Tepezza · 2025-04-11 · $27
See the published payment
Every published payment
AmgenMeals · 2025-04-11Tepezza$27
See earlier years (2024, 2023, 2019)

2024: $46

Payments by company in 2024
Astellas Pharma USIzervay$32
1 payment
  • Meals for Izervay · 2024-08-12 · $32
Genentech USAVabysmo$13
1 payment
  • Meals for Vabysmo · 2024-08-12 · $13

2023: $49

Payments by company in 2023
Astellas Pharma USNone$34
1 payment
  • Meals · 2023-10-15 · $34
Genentech USAVabysmo$15
1 payment
  • Meals for Vabysmo · 2023-08-10 · $15

2019: $123

Payments by company in 2019
Novartis PharmaceuticalsNone$123
1 payment
  • Meals · 2019-08-21 · $123

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
100.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1114919495
Licence
CA G057682
Trained
University of California, San Francisco School of Medicine, 1987 · 39 years ago
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00G576820
Taxonomy
Federal specialty code 207W00000X (207W00000X); Federal specialty code 207WX0107X (207WX0107X)
Mailing address
3300 Telegraph Ave, Oakland, CA, 94609
NPI first listed
2005-08-22
NPI last updated
2024-07-11
NPI record certified
2024-07-11

This is when the NPI record was last certified, not a medical board exam.